Clinical Trials Logo

Tetrahydrocannabinol clinical trials

View clinical trials related to Tetrahydrocannabinol.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01318369 Completed - Abdominal Pain Clinical Trials

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain

Delta-pain
Start date: October 2011
Phase: Phase 2
Study type: Interventional

The main goal of this trial is to study the efficacy of Namisol® after a single dose of Δ9-THC in the treatment of pain resulting from chronic pancreatitis. Objective measures of pain processing, e.g. encephalography (EEG) and quantitative sensory testing (QST), are included to provide insight in underlying nociceptive processing.

NCT ID: NCT00628706 Completed - Clinical trials for Magnetic Resonance Imaging

Investigating the Acute Effects of THC on Functional Brain Systems

FIX
Start date: April 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether THC, the main psychoactive ingredient in cannabis, affects functional brain systems underlying memory and reward.